BAILIE HARRIS: Open Payments
NPI 1427760255 · SMYRNA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,027 in 108 payments from 19 companies in 2025. Trend: 2023 $361 · 2024 $1,026 · 2025 $2,027
Food & beverage: $2,027
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $399 |
| GlaxoSmithKline, LLC. | 18 | $250 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $243 |
| Verona Pharma, Inc. | 11 | $203 |
| Grifols USA, LLC | 12 | $150 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $145 |
| GENZYME CORPORATION | 7 | $136 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $119 |
| Actelion Pharmaceuticals US, Inc. | 3 | $67 |
| Regeneron Healthcare Solutions, Inc. | 3 | $56 |
Products named: GLASSIA, Ohtuvayre, DUPIXENT, NUCALA, FASENRA, Prolastin-C Liquid, AIRSUPRA, LUMRYZ.
Industry payments across TN — which companies pay providers there.
